Posted on January 4,2017 by FDA Voice This past year was another successful year for the new drugs program in FDA’s Center for Drug Evaluation and Research(CDER).CDER reviewed and approved 22 novel drugs,most of whic...Posted on January 4,2017 by FDA Voice This past year was another successful year for the new drugs program in FDA’s Center for Drug Evaluation and Research(CDER).CDER reviewed and approved 22 novel drugs,most of which have the potential to add significant clinical展开更多
Posted on October 28,2016 by FDA Voice Here at FDA,we work diligently to be part of our nation’s solution to the opioid abuse epidemic.While there is no single solution to this complex problem,we continue to encourag...Posted on October 28,2016 by FDA Voice Here at FDA,we work diligently to be part of our nation’s solution to the opioid abuse epidemic.While there is no single solution to this complex problem,we continue to encourage efforts to develop new opioid formulations with abuse-deterrent properties that make it harder to abuse these powerful medications.展开更多
文摘Posted on January 4,2017 by FDA Voice This past year was another successful year for the new drugs program in FDA’s Center for Drug Evaluation and Research(CDER).CDER reviewed and approved 22 novel drugs,most of which have the potential to add significant clinical
文摘Posted on October 28,2016 by FDA Voice Here at FDA,we work diligently to be part of our nation’s solution to the opioid abuse epidemic.While there is no single solution to this complex problem,we continue to encourage efforts to develop new opioid formulations with abuse-deterrent properties that make it harder to abuse these powerful medications.
